The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions.

Fragoulis, George E; Brock, James; Basu, Neil; McInnes, Iain B; Siebert, Stefan

Fragoulis, George E; Brock, James; Basu, Neil; McInnes, Iain B; Siebert, Stefan.

Afiliação

Fragoulis GE; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom; First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece.
Brock J; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Basu N; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
McInnes IB; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Siebert S; Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom. Electronic address: stefan.siebert@glasgow.ac.uk.

J Allergy Clin Immunol ; 148(4): 941-952, 2021 10.

Article em En | MEDLINE | ID: mdl-34450118

Assuntos

Artrite Reumatoide/tratamento farmacológico; Doenças Inflamatórias Intestinais/tratamento farmacológico; Inibidores de Janus Quinases/uso terapêutico; Psoríase/tratamento farmacológico; Espondilite Anquilosante/tratamento farmacológico; Animais; Humanos

Palavras-chave

JAK inhibitors; biologics; inflammatory bowel disease; psoriasis; randomized controlled trials; rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Psoríase / Espondilite Anquilosante / Doenças Inflamatórias Intestinais / Inibidores de Janus Quinases Limite: Animals / Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Grécia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google